Medical societies agree that all pregnant women should beoffered prenatal screening for fetal abnormalities and thatNIPT is a major advance in screening methodologies.

nest represents a major advance in prenatal testing, providing highly sensitive and speci c answers about fetal chromosomal health—without the risks associated with invasive procedures, such as amniocentesis or chorionic villus sampling (CVS). Performed as early as 10 weeks gestation, the nest prenatal screening test demonstrates superb sensitivity and specificity for the most prevalent trisomies.